The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7

• Martyna Szpakowska,
• Ann M. Decker,
• Max Meyrath,
• Christie B. Palmer,
• Bruce E. Blough,
• Ojas A. Namjoshi,
• Andy Chevigné

Affiliations

Martyna Szpakowska

Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH)

Ann M. Decker

Center for Drug Discovery, RTI International

Max Meyrath

Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH)

Christie B. Palmer

Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH)

Bruce E. Blough

Center for Drug Discovery, RTI International

Ojas A. Namjoshi

Center for Drug Discovery, RTI International

Andy Chevigné

Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH)